Wall Street Zen Begins Coverage on Marinus Pharmaceuticals (NASDAQ:MRNS)
Investment analysts at Wall Street Zen assumed coverage on shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) in a research report issued on Wednesday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Marinus Pharmaceuticals Stock Down 0.2% NASDAQ:MRNS opened at $0.55 on Wednesday. Marinus Pharmaceuticals has a 52-week low of $0.22 […]
Investment analysts at Wall Street Zen assumed coverage on shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) in a research report issued on Wednesday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Marinus Pharmaceuticals Stock Down 0.2% NASDAQ:MRNS opened at $0.55 on Wednesday. Marinus Pharmaceuticals has a 52-week low of $0.22 […]
